A High-Affinity Near-Infrared Fluorescent Probe to Target Bombesin Receptors

PurposeThis study aimed to create new optical surgical navigation NIRF probes for prostate and breast cancers.ProceduresIR800-linker-QWAVGHLM-NH2 with linker = GSG, GGG, and G-Abz4 were synthesized and characterized. IC50 for bombesin receptors (BBN-R) in PC-3 prostate and T47D breast cancer cells, fluorescence microscopy in PC-3 cells, and NIRF imaging in mice PC-3 tumor xenografts were studied.ResultsGGG, GSG, and G-Abz4 derivatives had IC50 (nM) for BBN-R+ PC-3 cells = 187 ± 31, 56 ± 5, and 2.6 ± 0.2 and T47D cells = 383 ± 1, 57.4 ± 1.2, and 3.1 ± 1.1, respectively. By microscopy the Abz4 derivative showed the highest uptake, was competed with by BBN, and had little to no binding to BBN-R− cells. In NIRF imaging the G-Abz4 probe was brighter than GGG probe in BBN-R+ tissues in vivo and tissues, tumors, and tumor slices ex vivo. Uptake could be partially blocked in BBN-R+ pancreas but not visibly in tumor.ConclusionsLinker choice can dominate peptidic BBN-R binding. The G-Abz4 linker yields a higher affinity and specific BBN-R binder in this series of molecules.

[1]  L. Mazzucchelli,et al.  High expression of peptide receptors as a novel target in gastrointestinal stromal tumours , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[2]  J. Siegfried,et al.  Gastrin-releasing peptide receptor-mediated autocrine growth in squamous cell carcinoma of the head and neck. , 2002, Journal of the National Cancer Institute.

[3]  Eva M. Sevick-Muraca,et al.  Single-Dose Intravenous Toxicity Study of IRDye 800CW in Sprague-Dawley Rats , 2010, Molecular Imaging and Biology.

[4]  H. Sterenborg,et al.  Image‐guided surgery in head and neck cancer: Current practice and future directions of optical imaging , 2012, Head & neck.

[5]  Xiaoyuan Chen,et al.  Synthesis and evaluation of new iRGD peptide analogs for tumor optical imaging. , 2011, Bioorganic & medicinal chemistry letters.

[6]  Martin G Pomper,et al.  A low molecular weight PSMA-based fluorescent imaging agent for cancer. , 2009, Biochemical and biophysical research communications.

[7]  A. Nunn,et al.  Automated synthesis, characterization and biological evaluation of [(68)Ga]Ga-AMBA, and the synthesis and characterization of (nat)Ga-AMBA and [(67)Ga]Ga-AMBA. , 2010, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[8]  Samuel Achilefu,et al.  Synthesis, in vitro receptor binding, and in vivo evaluation of fluorescein and carbocyanine peptide-based optical contrast agents. , 2002, Journal of medicinal chemistry.

[9]  Thangavel Arunachalam,et al.  177Lu-AMBA: Synthesis and characterization of a selective 177Lu-labeled GRP-R agonist for systemic radiotherapy of prostate cancer. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  J. Stafford,et al.  Near-infrared Optical Imaging of Exposed Phosphatidylserine in a Mouse Glioma Model. , 2011, Translational oncology.

[11]  G. Clayman,et al.  Isolation of a peptide for targeted drug delivery into human head and neck solid tumors. , 2000, Cancer research.

[12]  J. Reubi,et al.  Overexpression of Gastrin-Releasing Peptide Receptors in Tumor-Associated Blood Vessels of Human Ovarian Neoplasms , 2007, Cellular oncology : the official journal of the International Society for Cellular Oncology.

[13]  J. Stafford,et al.  Increased exposure of phosphatidylethanolamine on the surface of tumor vascular endothelium. , 2011, Neoplasia.

[14]  Hak Soo Choi,et al.  Synthesis and in vivo fate of zwitterionic near-infrared fluorophores. , 2011, Angewandte Chemie.

[15]  M. Tweedle,et al.  Synthesis, stabilization and formulation of [177Lu]Lu-AMBA, a systemic radiotherapeutic agent for Gastrin Releasing Peptide receptor positive tumors. , 2008, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[16]  Seulki Lee,et al.  Peptides and peptide hormones for molecular imaging and disease diagnosis. , 2010, Chemical reviews.

[17]  J. Reubi,et al.  High expression of gastrin-releasing peptide receptors in the vascular bed of urinary tract cancers: promising candidates for vascular targeting applications. , 2009, Endocrine-related cancer.

[18]  Hak Soo Choi,et al.  Targeted zwitterionic near-infrared fluorophores for improved optical imaging , 2013, Nature Biotechnology.

[19]  A. Beck‐Sickinger,et al.  Cell Communication and Signaling BioMed Central Review Illuminating the life of GPCRs , 2009 .

[20]  H. Maecke,et al.  Radiolabeled Peptides: Valuable Tools for the Detection and Treatment of Cancer , 2012, Theranostics.

[21]  Hao Hong,et al.  In vivo near-infrared fluorescence imaging of CD105 expression during tumor angiogenesis , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[22]  Eva Sevick-Muraca,et al.  Characterization and performance of a near-infrared 2-deoxyglucose optical imaging agent for mouse cancer models. , 2009, Analytical Biochemistry.

[23]  Zhen Cheng,et al.  Fluorescent fructose derivatives for imaging breast cancer cells. , 2007, Bioconjugate chemistry.

[24]  Tiancheng Liu,et al.  Spacer length effects on in vitro imaging and surface accessibility of fluorescent inhibitors of prostate specific membrane antigen. , 2011, Bioorganic & medicinal chemistry letters.

[25]  C. Besch-Williford,et al.  Near‐infrared fluorescence imaging of gastrin releasing peptide receptor targeting in prostate cancer lymph node metastases , 2013, The Prostate.

[26]  J. Reubi.  Peptide receptors as molecular targets for cancer diagnosis and therapy. , 2003, Endocrine reviews.

[27]  J. Reubi,et al.  Peptide-Based Probes for Cancer Imaging , 2008, Journal of Nuclear Medicine.

[28]  Zhen Cheng,et al.  Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors. , 2011, Bioconjugate chemistry.

[29]  R. Tsien,et al.  Fluorescence-guided surgery with live molecular navigation — a new cutting edge , 2013, Nature Reviews Cancer.

[30]  Vasilis Ntziachristos,et al.  Intraoperative Near-Infrared Fluorescence Tumor Imaging with Vascular Endothelial Growth Factor and Human Epidermal Growth Factor Receptor 2 Targeting Antibodies , 2011, The Journal of Nuclear Medicine.

[31]  Ping Yu,et al.  In Vitro and In Vivo Evaluation of Alexa Fluor 680-Bombesin[7–14]NH2 Peptide Conjugate, a High-Affinity Fluorescent Probe with High Selectivity for the Gastrin-Releasing Peptide Receptor , 2007, Molecular imaging.

[32]  H. Ohki‐Hamazaki,et al.  Development and function of bombesin-like peptides and their receptors. , 2005, The International journal of developmental biology.

[33]  D. M. Olive,et al.  In vivo imaging of xenograft tumors using an epidermal growth factor receptor-specific affibody molecule labeled with a near-infrared fluorophore. , 2010, Neoplasia.

[34]  J. Reubi,et al.  Bombesin Receptor Subtypes in Human Cancers: Detection with the Universal Radioligand 125I-[d-TYR6, β-ALA11, PHE13, NLE14] Bombesin(6–14) , 2002 .

[35]  Marilyn E. Morris,et al.  Pharmacokinetics, Lymph Node Uptake, and Mechanistic PK Model of Near-Infrared Dye-Labeled Bevacizumab After IV and SC Administration in Mice , 2012, The AAPS Journal.

[36]  Eva M. Sevick-Muraca,et al.  Single dose toxicity study of IRDye 800CW in Sprague-Dawley rats , 2010, BiOS.

[37]  J. Reubi,et al.  Bombesin receptor subtypes in human cancers: detection with the universal radioligand (125)I-[D-TYR(6), beta-ALA(11), PHE(13), NLE(14)] bombesin(6-14). , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[38]  J C Reubi,et al.  Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation. , 1999, Cancer research.

[39]  Samantha V. Sublett,et al.  Evaluation of the pharmacokinetic effects of various linking group using the 111In-DOTA-X-BBN(7-14)NH2 structural paradigm in a prostate cancer model. , 2008, Bioconjugate chemistry.

[40]  E. Krenning,et al.  Candidates for peptide receptor radiotherapy today and in the future. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[41]  H. Maecke,et al.  Radiopharmaceutical development of radiolabelled peptides , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[42]  Samuel Achilefu,et al.  Rational approach to select small peptide molecular probes labeled with fluorescent cyanine dyes for in vivo optical imaging. , 2011, Biochemistry.

[43]  D. M. Olive,et al.  A systematic approach to the development of fluorescent contrast agents for optical imaging of mouse cancer models. , 2007, Analytical biochemistry.

[44]  Eva M. Sevick-Muraca,et al.  Dual-Labeling Strategies for Nuclear and Fluorescence Molecular Imaging: A Review and Analysis , 2011, Molecular Imaging and Biology.

[45]  Holger Kalthoff,et al.  Near-infrared molecular imaging of tumors via chemokine receptors CXCR4 and CXCR7 , 2011, Clinical & Experimental Metastasis.